Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gen Era Diagnostics is a leading Turkish provider of molecular diagnostics products and services. The company offers a broad portfolio including genetic analysis, exome sequencing, next-generation sequencing (NGS), real-time PCR, digital droplet PCR (ddPCR), and bioinformatics solutions. It supports clinical laboratories with high-quality reagents, instruments, reference materials for assay validation/quality control, and distributes technologies from global partners. The company is active in precision oncology through partnerships such as with Molecular Health for the MH Guide platform to standardize genomic data interpretation in cancer care across multiple labs in Turkey.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gen Era Diagnostics.